David Ambrose Selected Research

1- (4- (1,1- dimethylheptyl)- 2,6- dimethoxyphenyl)- 3- methylcyclohexanol

1/2022

Modulation of Morphine Analgesia, Antinociceptive Tolerance, and Mu-Opioid Receptor Binding by the Cannabinoid CB2 Receptor Agonist O-1966.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David Ambrose Research Topics

Disease

2	Inflammation (Inflammations) 01/2022 - 01/2020
2	Neoplasms (Cancer) 01/2018 - 09/2015
1	Hyperalgesia 01/2022
1	Chronic Pain 01/2022
1	HIV Infections (HIV Infection) 01/2020
1	Opioid-Related Disorders (Opiate Addiction) 01/2020
1	Neuroinflammatory Diseases 01/2020
1	Infections 01/2020
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 09/2015

Drug/Important Bio-Agent (IBA)

2	Morphine (MS Contin)FDA LinkGeneric 01/2022 - 01/2020
1	1- (4- (1,1- dimethylheptyl)- 2,6- dimethoxyphenyl)- 3- methylcyclohexanolIBA 01/2022
1	CannabinoidsIBA 01/2022
1	CB2 Cannabinoid ReceptorIBA 01/2022
1	SmokeIBA 01/2020
1	Opiate AlkaloidsIBA 01/2020
1	Chimeric Antigen ReceptorsIBA 09/2015

Therapy/Procedure

1	Immunotherapy 01/2018
1	Therapeutics 09/2015